- Markus Koester
- Director, Corporate Department Research Coordination
- Boehringer Ingelheim, Germany
Markus Koester is a member of the Discovery Research organization of Boehringer Ingelheim. In his role as Director Discovery Research Coordination he provides operational and strategic support – mostly in the field of open innovation. Markus has established scientific crowdsourcing as a new open innovation tool to attract externally generated new therapeutic concepts for Boehringer Ingelheim’s preclinical pipeline. Most recently, he was deeply involved in the launch opnMe.com, the new open innovation portal of Boehringer Ingelheim with the goal to share selected preclinical molecules for scientific investigation with scientists all over the world. Over his professional career Markus has accumulated broad experience in pharmaceutical drug discovery, development and innovation – both in research and commercial roles. Prior to his current role, he was Council Chair for R&D Competitive Intelligence at Boehringer Ingelheim and Head of Global Business Intelligence Oncology at Merck KGaA which included market research, forecasting and competitive intelligence. Markus is a Molecular Biologist by training and obtained his PhD at the Technical University of Braunschweig, Germany, in the area of Developmental Biology.